CAS No. :	1802220-02-5
Formula :	C₁₈H₁₈FN₅O₂
M.W :	355.37
SMILES Code :	O=C1NC[C@H](C)OC2=CC=C(F)C=C2[C@@H](C)NC3=NC4=C1C=NN4C=C3
MDL No. :	MFCD31544350
InChI Key :	FIKPXCOQUIZNHB-WDEREUQCSA-N
Pubchem ID :	135565923

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

KM12SM cells	1 μM	72 h	KM12SM cells were sensitive to repotrectinib, IC50 of 1.2 nM	Cancer Sci. 2022 Jul;113(7):2323-2335.
IRC and KM12 cells	1-5000 nM	72 hours	To assess the effect of Selpercatinib on the growth inhibition and TRK-mediated signaling in NTRK fusion-positive tumor cells. Results showed that Selpercatinib significantly inhibited tumor cell growth and TRK signaling.	Br J Cancer. 2024 Aug;131(3):601-610.
Ba/F3_G595R cells	1 μM	72 h	Ba/F3_G595R cells were sensitive to repotrectinib	Cancer Sci. 2022 Jul;113(7):2323-2335.
Ba/F3_WT cells	1 μM	72 h	Ba/F3_WT cells were sensitive to repotrectinib	Cancer Sci. 2022 Jul;113(7):2323-2335.
M3B cells	1 μM	72 h	M3B cells were resistant to repotrectinib, IC50 of 295.7 nM	Cancer Sci. 2022 Jul;113(7):2323-2335.
YU1079	0.097 μM	72 h	To evaluate the anti-tumor activity of Repotrectinib in crizotinib-resistant ROS1 G2032R mutation models, results showed that Repotrectinib significantly inhibited the growth of YU1079 cells.	Clin Cancer Res. 2020 Jul 1;26(13):3287-3295.
YU1078	0.021 µM	72 h	To evaluate the anti-tumor activity of Repotrectinib in treatment-naïve ROS1-rearranged NSCLC models, results showed that Repotrectinib significantly inhibited the growth of YU1078 cells.	Clin Cancer Res. 2020 Jul 1;26(13):3287-3295.
SK-N-BE	510.8 ± 16.94 nM	5 days	Repotrectinib has a weaker inhibitory effect on the proliferation of non-ALK-addicted neuroblastoma cells SK-N-BE.	Sci Rep. 2019 Dec 18;9(1):19353.
SK-N-AS	594.8 ± 47.3 nM	5 days	Repotrectinib has a weaker inhibitory effect on the proliferation of non-ALK-addicted neuroblastoma cells SK-N-AS.	Sci Rep. 2019 Dec 18;9(1):19353.
Kelly	310.9 ± 7.9 nM	5 days	Repotrectinib inhibits proliferation of ALK-addicted neuroblastoma cells and reduces phosphorylation levels of pY1604-ALK, pERK5, pSTAT3, p-p70 S6K, pAKT, and pERK.	Sci Rep. 2019 Dec 18;9(1):19353.
CLB-GE	259.4 ± 6.3 nM	5 days	Repotrectinib inhibits proliferation of ALK-addicted neuroblastoma cells and reduces phosphorylation levels of pY1604-ALK, pERK5, pSTAT3, p-p70 S6K, pAKT, and pERK.	Sci Rep. 2019 Dec 18;9(1):19353.
CLB-BAR	124.1 ± 4.89 nM	5 days	Repotrectinib inhibits proliferation of ALK-addicted neuroblastoma cells and reduces phosphorylation levels of pY1604-ALK, pERK5, pSTAT3, p-p70 S6K, pAKT, and pERK.	Sci Rep. 2019 Dec 18;9(1):19353.
NIH-3T3-tv-a cells	100 nM	5 days	To evaluate the growth inhibitory effect of Repotrectinib on TPM3-NTRK1-G595R mutant spheroids, results showed that Repotrectinib significantly inhibited the growth of mutant spheroids.	Cell Rep. 2024 Oct 22;43(10):114829.
NIH-3T3-tv-a cells	100 nM	5 days	To evaluate the growth inhibitory effect of Repotrectinib on TPM3-NTRK1-F589L mutant spheroids, results showed that Repotrectinib significantly inhibited the growth of mutant spheroids.	Cell Rep. 2024 Oct 22;43(10):114829.
NIH-3T3-tv-a cells	100 nM	5 days	To evaluate the growth inhibitory effect of Repotrectinib on NTRK fusion-driven spheroids, results showed that Repotrectinib significantly inhibited the growth of spheroids.	Cell Rep. 2024 Oct 22;43(10):114829.
KM12 cells	<0.03 nM	4 h	Repotrectinib was the most potent inhibitor of TRKA autophosphorylation, with an IC50 value less than 0.03 nM.	Mol Cancer Ther. 2021 Dec;20(12):2446-2456.
Ba/F3 cells	<0.2 nM	72 h	Repotrectinib showed the highest potency against wild-type TRKA, TRKB, and TRKC fusions, with IC50 values less than 0.2 nM.	Mol Cancer Ther. 2021 Dec;20(12):2446-2456.
HCC78 ROS1L2026M	1 - 5000 nM	120 h	To evaluate the inhibitory effect of Repotrectinib on ROS1L2026M mutant cells, results showed significant resistance of ROS1L2026M cells to Repotrectinib	J Transl Med. 2024 Mar 3;22(1):234.
HCC78 ROS1G2032R	1 - 5000 nM	120 h	To evaluate the inhibitory effect of Repotrectinib on ROS1G2032R mutant cells, results showed significant resistance of ROS1G2032R cells to Repotrectinib	J Transl Med. 2024 Mar 3;22(1):234.

Mice	YU1078 xenograft model	Oral	15 mg/kg	Twice daily, for 21 days	To evaluate the anti-tumor activity of Repotrectinib in the YU1078 xenograft model, results showed that Repotrectinib significantly inhibited tumor growth and delayed tumor recurrence.	Clin Cancer Res. 2020 Jul 1;26(13):3287-3295.
Mice	Neuroblastoma xenograft model	Oral	20 mg/kg, twice daily	Twice daily for 14 days	Repotrectinib significantly inhibits tumor growth in a neuroblastoma xenograft model, with a tumor growth inhibition (TGI) of 87.07%, and animals gained weight.	Sci Rep. 2019 Dec 18;9(1):19353.
Mice	NTRK fusion-driven glioma models	Intraperitoneal (i.p.) injection	20 mg/kg	Twice a day for 25 hours	To evaluate the therapeutic effect of Repotrectinib on NTRK fusion-driven gliomas, results showed that Repotrectinib significantly reduced p-ERK and p-S6 levels in tumor tissue and induced apoptosis.	Cell Rep. 2024 Oct 22;43(10):114829.
Nude mice	NIH3T3 LMNA–TRKA xenograft model	Oral	3 mg/kg, 10 mg/kg, 30 mg/kg	Twice daily, continuous treatment	Repotrectinib demonstrated significant antitumor activity in the LMNA–TRKAG595R xenograft model, achieving 95% tumor growth inhibition, 19% tumor regression, and 46% tumor regression at doses of 3 mg/kg, 10 mg/kg, and 30 mg/kg, respectively.	Mol Cancer Ther. 2021 Dec;20(12):2446-2456.
SHO mice	Brain metastasis model	Oral	15 mg/kg	Daily, continuous treatment	Single-agent repotrectinib treatment significantly inhibited tumor growth, and the combination with Gefitinib and Trametinib further prolonged mouse survival	Cancer Sci. 2022 Jul;113(7):2323-2335.

NCT06352528	Hepatic Impairment\|Healthy Vol... More >>unteers Less <<	PHASE1	RECRUITING	2025-07-24	Local Institution - 0006, Miam... More >>i Lakes, Florida, 33014-2811, United States\|Panax Clinical Research, Miami Lakes, Florida, 33014, United States\|Local Institution - 0005, Orlando, Florida, 32809-3017, United States\|Orlando Clinical Research Center, Orlando, Florida, 32809, United States\|Local Institution - 0004, San Antonio, Texas, 78215, United States\|Texas Liver Institute, San Antonio, Texas, 78215, United States Less <<
NCT06552234	NSCLC Stage IV\|NSCLC, Stage II... More >>I Less <<	PHASE2	RECRUITING	1931-09-01	CH Aix-en-Provence, Aix-en-Pro... More >>vence, Bouches Du Rh?ne, France\|AP-HM, Marseille, Bouches Du Rh?ne, France\|HIA Sainte Anne, Toulon, Var, France\|CHU Angers, Angers, France\|CHU Bordeaux, Bordeaux, France\|CHU Brest, Brest, France\|Centre Fran?ois Baclesse, Caen, France\|CH Chambéry, Chambéry, France\|H?pitaux civils de Colmar, Colmar, France\|CHI Créteil, Créteil, France\|CHD Vendée, La Roche-sur-Yon, France\|CHRU Lille, Lille, France\|CHU Limoges, Limoges, France\|Hospices Civils de Lyon, Lyon, France\|CH Cornouaille, Quimper, France\|CHU Rennes, Rennes, France\|CHU Rouen, Rouen, France\|H?pital Foch, Suresnes, France\|CHU Toulouse, Toulouse, France\|H?pitaux Nord-Ouest, Villefranche-sur-Sa?ne, France Less <<
NCT05926232	-		AVAILABLE	-	-
NCT06315010	NSCLC\|Brain Metastases\|ROS1 Ge... More >>ne Rearrangement Less <<	PHASE2	NOT_YET_RECRUITING	2025-04-28	-

{[proInfo.proName]}

CAS No.: 1802220-02-5

{[proInfo.proName]}

CAS No.: 1802220-02-5

Alternative Products

Product Details of Repotrectinib

Safety of Repotrectinib

Related Pathways of Repotrectinib

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.81mL 0.56mL 0.28mL	14.07mL 2.81mL 1.41mL	28.14mL 5.63mL 2.81mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed